Morning Buzz: Apple (AAPL), Yahoo (YHOO), Trina Solar (TSL), Akebia Therapeutics (AKBA), FXCM Inc. (FXCM)

Apple Inc (AAPL) – The company’s Apple Music service won a deal with pop star Taylor Swifts to exclusively release a concert video of her recent 1989 world tour.

Both Swift and the Apple Music official account tweeted the news on Sunday Dec. 13.

Shares of Apple are down 1.84% at $111.10 in early morning trading on Monday.

Yahoo! Inc. (YHOO) – Yahoo’s major investors are increasing their pressure on the company. Canyon Capital Advisors LLC, a Los Angeles investment-based firm that ranks among Yahoo’s 15 largest shareholders, sent a letter to the board Friday urging the web portal to sell either its core internet business or the entire company, according to the Journal.

Yahoo was last down marginally to $32.90 at 10:07 a.m. in New York today.

Shares of Trina Solar Limited (TSL) are higher by nearly 11% to $10.58 in morning trading on Monday after the company announced it received a buyout offer valuing the company at over $980 million, or $11.60 per share in cash per ADS, from chairman and CEO Jifan Gao and Shanghai Xingsheng Equity Investment Management. The go-private proposal represents a more than 21% premium over the stock’s closing price on Dec. 11, 2015.

Akebia Therapeutics, Inc. (AKBA) shares surged 11.28% to $10.85 in early trading after the company announced a collaboration with Mitsubishi Tanabe Pharma (MTZPY) to develop and commercialize Vadadustat in Asia, an oral therapy for the treatment of anemia related to chronic kidney disease.

Under the terms of the agreement, MTPC will make payments totaling $100 million for costs associated with the global Phase 3 program for vadadustat, including $40 million upon signing. In addition, Akebia is eligible to receive up to approximately $250 million in additional milestone payments, based upon achievement of certain development and sales milestones.

Shares of FXCM Inc. (FXCM) are up $1.03, or 19.43%, at $6.33, after the company this morning provided an update regarding its relationship with Leucadia and its stock repurchase program. Fxcm said discussions with Leucadia remain ongoing.

Be the first to comment

Leave a Reply

Your email address will not be published.


*